In the present study, we demonstrated that inducing PKR in lung cancer cells activates the AMPK protein independent of the LKB1, TAK1, and CaMKKβ pathways by increasing AMP levels and decreasing ATP levels. The gene discussed is EIF2AK2; the disease is lung carcinoma.